Cofactor Genomics

Saint Louis, MO · Privately Held (backing)

Developer of a precision diagnostic assay designed to predict immune responses in oncology. Cofactor Genomics is based in Saint Louis, MO. It was valued at $41.9 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $28.7 million across 2 recorded rounds; the latest was a $6.9 million early-stage round in Dec 2021.

PMV mark · valuation
$41.9M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$28.7M
Last round
Early Stage VC
Dec 2021

Who backs Cofactor Genomics?

30 investors
InvestorType
Y CombinatorOther
Menlo VenturesVenture capital
DCVCVenture capital
AME Cloud VenturesVenture capital
SVB Financial Group (Dallas)Other
Fifty YearsVenture capital
7percent VenturesVenture capital
Labcorp Venture FundVenture capital
Refactor CapitalVenture capital
Wilson Sonsini Goodrich & RosatiOther
+ 20 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cofactor Genomics investors

30 investors are on record for Cofactor Genomics, including Y Combinator, Menlo Ventures, DCVC and AME Cloud Ventures. By type, the record holds 12 venture capital firms and 1 fund of funds. The early-stage round in Dec 2021 drew 9 investors.

Free account
More of Cofactor Genomics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Cofactor Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like Cofactor Genomics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View